Michigan House Bill HB5204

Michigan 2025-2026 Regular Session

• Introduced: 11/4/25
• Refer: 11/4/25

Caption

Insurance: health insurers; prescription drug coverage for metastatic cancer; prohibit certain conditions. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406rr.

Impact

The proposed changes in HB 5204 are expected to significantly improve the accessibility of prescription drugs for patients suffering from advanced metastatic cancer. By eliminating the requirement for patients to demonstrate failure on alternative medications before receiving coverage, the bill aims to enhance the quality of care for this vulnerable patient population. This could lead to better health outcomes as patients would be able to receive the most appropriate treatments in a timely manner.

Summary

House Bill 5204 seeks to amend the Michigan insurance code by adding section 3406rr, which directly addresses coverage policies for prescription drugs used to treat advanced metastatic cancer. This bill prohibits health insurers from requiring patients to fail on different prescriptions or to prove a lack of efficacy on other drugs before they can be covered for medications specifically targeting their condition. The intent of the bill is to ensure that patients have timely access to effective treatment options without unnecessary barriers that can delay care.

Contention

Despite its intent to improve access to needed treatments for cancer patients, HB 5204 may face pushback from insurance companies concerned about potential increases in costs due to heightened coverage requirements. Critics may argue that the bill could lead to a surge in claims, impacting insurance premiums overall. Proponents of the bill, however, emphasize the ethical responsibility of ensuring patients are not forced to endure ineffective treatments before obtaining the necessary care, framing the legislation as fundamentally beneficial for public health.